Search research articles
Contact Us
Filters
Showing results (141-150 of 149) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 149 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 4, 2001
Phase II study of vinorelbine in patients with androgen-independent prostate cancer
S Oudard, A Caty, Y Humblet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 31, 2009
A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802)
M Ychou, J-L Raoul, J-Y Douillard, et al.
British Journal of Cancer
|
August 14, 2003
Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002)
R Bugat, A Bataillard, T Lesimple, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2003
Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology trial)
L Zelek, R Bugat, D Cherqui, et al.
British Journal of Cancer
|
September 11, 2003
Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial
C-H Köhne, R Catane, B Klein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2002
First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin
J Cassidy, C Twelves, E Van Cutsem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2001
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study
E Van Cutsem, C Twelves, J Cassidy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy
P Rougier, R Bugat, J Y Douillard, et al.
Annales De Pathologie
|
November 28, 2006
[Recommendations for the management of gastro-intestinal stromal tumors]
A Le Cesne, B Landi, S Bonvalot, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 149) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 149 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 4, 2001
Phase II study of vinorelbine in patients with androgen-independent prostate cancer
S Oudard, A Caty, Y Humblet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 31, 2009
A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802)
M Ychou, J-L Raoul, J-Y Douillard, et al.
British Journal of Cancer
|
August 14, 2003
Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002)
R Bugat, A Bataillard, T Lesimple, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2003
Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology trial)
L Zelek, R Bugat, D Cherqui, et al.
British Journal of Cancer
|
September 11, 2003
Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial
C-H Köhne, R Catane, B Klein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2002
First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin
J Cassidy, C Twelves, E Van Cutsem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2001
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study
E Van Cutsem, C Twelves, J Cassidy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy
P Rougier, R Bugat, J Y Douillard, et al.
Annales De Pathologie
|
November 28, 2006
[Recommendations for the management of gastro-intestinal stromal tumors]
A Le Cesne, B Landi, S Bonvalot, et al.
Page
of 15